Myeloid malignancies in the real-world: Occurrence, progression and survival in the UK’s population-based Haematological Malignancy Research Network 2004–15

Highlights • ICD-O3 analysis of “real-world” data revealed novel variations by sub-type, sex and age. • Males experience higher incidence and worse survival than females; the reasons for this are unknown. • Lack of concordance in the use of standard populations impacts markedly on the comparability of national incidence estimates. • Lack of concordance in recording progressions impacts on the comparability of national AML occurrence & survival estimates.